 |
Home
Services
Experts
News
Publications
Presentations
Contact DEGGE
_____________________
B.R.I.D.G.E. TO DATA®
PERI Inc.
"Kidz with Leukemia: A Space Adventure"
"Conquering Cancer Network"
|
The Degge Group, Ltd. provides consulting services in pharmacoepidemiology, risk management, clinical drug safety, and pharmacovigilance to the pharmaceutical and medical product sector.
Degge's staff has contributed to the burgeoning fields of pharmacoepidemiology and pharmacovigilance for over two decades and has worked to enhance the understanding of drug safety, drug use, natural history of disease, pharmacoeconomic and outcomes research, and recently risk evaluation and mitigation strategies (REMS).
Degge will help you identify and analyze key factors and find the right solution.
Announcements:
Judith K Jones, MD, PhD recently presented at the 6th Asian Conference on Pharmacoepidemiology in Beijing, China, October 28-30, 2011. In her keynote speech, she spoke about
‘Risk Management Practice in US & EU and Globally’.
She also chaired a plenary session on ‘Drug Utilization Studies in Hospital And Institutional Pharmacy Policy And Practice’.
The Degge Group, Ltd. presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (Chicago).
SUNDAY, 14 AUGUST
PRE-CONFERENCE EDUCATIONAL SESSION
Introduction to Therapeutic Risk Management and Evaluation: What are we learning from the evaluations of Risk Management Programs (RMP) and REMS?
Judith K Jones, FISPE, Workshop for participants to develop/review an assessment plan
MONDAY, 15 AUGUST
POSTER SESSION A #120
An Analysis of Registries with Birth Defect Data Using an Online Database Resource. Anokhi Kapasi, Sharmila Kamani, Bao Nguyen-Khoa, Earl Goehring, Jr, Varinder Singh, Judith K Jones
WEDNESDAY, 17 AUGUST
CONCURRENT SESSION:
Not Your "Typical" Psychotropics
Moderators: Judith K Jones, FISPE & Natasha Chih-Ying Chen
WORKSHOP/SYMPOSIUM
Active Surveillance for Follow-on Biologics (Biologics SIG Symposium)
Moderators: Earl Goehring, Jr & Robert Chen
-
Emerging Standards for Evaluating Follow-on Biologics, Judith K Jones, FISPE
-
Population based systems for active surveillance – applicability to biologic products, Miriam CJM Sturkenboom, FISPE
-
Biosimilars and Comparative Effectiveness: Specialty Pharmacy as a Critical Component of an Active Surveillance System, Jonathon Morris
-
Can lessons learned from systems used to monitor vaccines inform post approval surveillance of follow-on biologics? Edward Zissman
|
The Degge Group, Ltd.
Consulting in
clinical drug safety, pharmacovigilance, and pharmacoepidemiology since 1988.
1616 North Fort Myer Drive, Suite 1430
Arlington, Virginia 22209 USA
1 (888) 413-3443
Phone: +1 (703) 276-0067 || Fax: +1 (703) 276-0069
|